Gene therapy reveals unexpected immunity to dystrophin in patients with Duchenne muscular dystrophy
Thursday, October 7, 2010 - 03:33
in Health & Medicine
An immune reaction to dystrophin, the muscle protein that is defective in patients with Duchenne muscular dystrophy, may pose a new challenge to strengthening muscles of patients with this disease, suggests a new study appearing in the October 7, 2010, issue of The New England Journal of Medicine.
